{"schema_version":"secwatch.filing_event.v1","accession":"0001844505-24-000076","form_type":"8-K","ticker":"QTI","cik":"0001844505","company_name":"QT IMAGING HOLDINGS, INC.","filed_at":"2024-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.999980+00:00","generated_at":"2026-05-30T01:04:57.276608+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"QT Imaging Q3 scanner sales $0.9M (65% gross margin); amends convertible note to $8.6M; insider PIPE $2.56M","bullets":["Generated $0.9M scanner sales revenue with 65% gross margin in Q3 2024.","Completed engineering and clinical feasibility study with strategic partner.","Amended $10M convertible note with YA II PN: principal reduced to $8.6M, maturity extended to March 2026.","Board members and affiliates invested $2.56M PIPE at ~10% premium; surrened $1.56M note and $1M new cash.","Third-year renewal of NIH/NCI research grant signed during quarter."],"urls":{"canonical":"https://secwatch.observer/filing/0001844505-24-000076","json":"https://secwatch.observer/filing/0001844505-24-000076.json","markdown":"https://secwatch.observer/filing/0001844505-24-000076.md","text":"https://secwatch.observer/filing/0001844505-24-000076.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1844505/000184450524000076/0001844505-24-000076-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1844505/000184450524000076/qti-20241113.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T01:04:57.276608+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}